医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

幹細胞

Patients with Severe Paralysis Use Stentrode Brain-Computer Interface to Text, Email, Shop, Bank Online, First-in-human Study Reports

Patients with Severe Paralysis Use Stentrode Brain-Computer Interface to Text, Email, Shop, Bank Online, First-in-human Study Reports

その他ヘルスバイオテクノロジーヘルスケアヘルス一般医療管理幹細胞心臓学放射線学　 TimeLine: Bank Online Email First-in-human Study Reports Patients with Severe Paralysis Use Stentrode Brain-Computer Interface to Text Shop

2020年10月28日

IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

AIDS バイオテクノロジーヘルスケアヘルス一般幹細胞感染症製薬　 TimeLine: and Ensure Prompt and Equitable Global Access and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID IAVI Merck

2020年10月22日

インドのカストゥルバ医科大学が優勝

インドのカストゥルバ医科大学が優勝

ヘルスケアヘルス一般幹細胞糖尿病　 TimeLine: インドカストゥルバ医科大学優勝

2020年10月21日

印度Kasturba医学院在NCRM NICHE 2020上赢得第15届Fujio Cup Quiz

印度Kasturba医学院在NCRM NICHE 2020上赢得第15届Fujio Cup Quiz

ヘルスケアヘルス一般幹細胞糖尿病　 TimeLine: 印度Kasturba医学院在NCRM NICHE 2020上赢得第15届Fujio Cup Quiz

2020年10月20日

Kasturba Medical College, India Wins XV Fujio Cup Quiz in NCRM NICHE 2020

Kasturba Medical College, India Wins XV Fujio Cup Quiz in NCRM NICHE 2020

ヘルスケアヘルス一般幹細胞糖尿病　 TimeLine: in NCRM NICHE India Wins XV Fujio Cup Quiz Kasturba Medical College

2020年10月19日

Qihan Biotech Unveils its Program to Develop Immunologically Privileged Human Stem Cells for Allogeneic Cell Therapies

Qihan Biotech Unveils its Program to Develop Immunologically Privileged Human Stem Cells for Allogeneic Cell Therapies

バイオテクノロジーヘルスケア幹細胞腫瘍学製薬遺伝学　 TimeLine: Immunologically Privileged Human Stem Cells for Allogeneic Cell Therapies its Program to Develop Qihan Biotech Unveils

2020年10月14日

EasyCOV, the Virological Saliva Test for COVID19 Confirms Its Excellent Results: a Sensitivity of 88% and a Specificity of 99% in 40 Min

その他ヘルスバイオテクノロジーヘルスケア医療用品幹細胞感染症病院臨床試験製薬　 TimeLine: EasyCOV the Virological Saliva Test for COVID19 Confirms Its Excellent Results

2020年10月02日

Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees

Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees

その他ヘルスバイオテクノロジーヘルスケアヘルス一般外科幹細胞病院腫瘍学製薬遺伝学　 TimeLine: Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees

2020年09月30日

Gunze Provides Biodegradable Scaffolds for TEVG Clinical Trial to Be Conducted at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to Improve Pediatric Patient Clinical Outcome

Gunze Provides Biodegradable Scaffolds for TEVG Clinical Trial to Be Conducted at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to Improve Pediatric Patient Clinical Outcome

バイオテクノロジーヘルスケア外科幹細胞臨床試験　 TimeLine: Gunze Provides Biodegradable Scaffolds for TEVG Clinical Trial to Be Conducted at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to Improve Pediatric Patient Clinical Outcome

2020年09月24日

Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte

Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte

バイオテクノロジーヘルスケア医療機器幹細胞腫瘍学臨床試験製薬遺伝学　 TimeLine: from Incyte MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate Promega Developing OncoMate

2020年09月22日